Business

Trump signs order to reduce childhood vaccines, falsely linking shots to autism

The US President’s directive builds on ongoing administration attempts to alter the childhood vaccination timetable, despite the order’s baseless claims regarding autism.

Author
Owen Mercer
Markets and Finance Editor
Published
Draft
Source: CNBC · original
Trump signs executive order calling for fewer childhood vaccines, falsely linking shots to autism
Executive action supports HHS Secretary Robert F. Kennedy Jr’s efforts to reshape immunisation schedule

US President Donald Trump has signed an executive order aimed at reducing the number of childhood vaccines, a move that explicitly links immunisations to autism. The directive supports the efforts of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr to reshape the vaccination schedule.

The order builds on the Trump administration’s ongoing efforts to alter the childhood shot timetable under Kennedy Jr, a longtime vaccine skeptic. While the specific details regarding which vaccines are affected or the timeline for implementation remain unspecified, the policy shift marks a significant departure from established medical guidelines.

The executive action is categorised under politics and markets, reflecting its potential policy implications. However, the core content focuses on health policy changes driven by the administration’s stance rather than direct financial market mechanics.

The source material from CNBC notes that the order falsely links shots to autism. This claim is scientifically unfounded and stands in contrast to the consensus of the medical community. The administration’s approach prioritises political objectives over established scientific evidence regarding vaccine safety.

Kennedy Jr’s role as HHS Secretary places him at the centre of this policy shift. His involvement signals a continued push to modify the standard immunisation protocols, a trend that has been developing throughout the current administration’s tenure.

The lack of specific implementation details leaves the exact scope of the changes unclear. Investors and observers are monitoring the situation for any downstream effects on healthcare sectors, though no immediate market impact has been detailed in the source material.

The directive underscores the administration’s willingness to challenge established public health norms. As the policy unfolds, the focus remains on how these changes will be executed and their potential long-term effects on public health infrastructure.

Continue reading

More from Business

Read next: Trump asserts control of Hormuz, demands reparations as US-Iran tensions harden
Read next: Florida’s political shift from swing state to MAGA stronghold
Read next: Startups claim embryo screening can extend to IQ, sparking scepticism